Australia markets closed

Genmab A/S (GNMSF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
289.74+13.27 (+4.80%)
At close: 03:40PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 18.08B
Enterprise value 13.98B
Trailing P/E 24.29
Forward P/E 25.91
PEG ratio (5-yr expected) 1.25
Price/sales (ttm)7.47
Price/book (mrq)4.01
Enterprise value/revenue 0.79
Enterprise value/EBITDA 1.96

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-31.69%
S&P500 52-week change 322.38%
52-week high 3426.50
52-week low 3262.00
50-day moving average 3291.29
200-day moving average 3320.54

Share statistics

Avg vol (3-month) 3996
Avg vol (10-day) 3890
Shares outstanding 564.66M
Implied shares outstanding 666.17M
Float 864.64M
% held by insiders 10.01%
% held by institutions 147.75%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 30.74%
Operating margin (ttm)19.33%

Management effectiveness

Return on assets (ttm)10.63%
Return on equity (ttm)18.32%

Income statement

Revenue (ttm)17.78B
Revenue per share (ttm)272.41
Quarterly revenue growth (yoy)45.20%
Gross profit (ttm)N/A
EBITDA 5.95B
Net income avi to common (ttm)5.47B
Diluted EPS (ttm)11.94
Quarterly earnings growth (yoy)486.30%

Balance sheet

Total cash (mrq)29.58B
Total cash per share (mrq)453.03
Total debt (mrq)1.01B
Total debt/equity (mrq)3.11%
Current ratio (mrq)12.46
Book value per share (mrq)497.63

Cash flow statement

Operating cash flow (ttm)5.66B
Levered free cash flow (ttm)3.79B